Similar Search Results

The economy and the 1976 elections

Rubin, Daniel - In: Political affairs : pa ; a Marxist monthly ; a … 55 (1976) 6, pp. 1-13,34

Persistent link: https://www.econbiz.de/10002716084

The fight against inflation and unemployment

Rubin, Daniel - In: Political affairs : pa ; a Marxist monthly ; a … 54 (1975) 1, pp. 21-31

Persistent link: https://www.econbiz.de/10002716100

The tax issue in the struggle for social progress

Rubin, Daniel - In: Political affairs : pa ; a Marxist monthly ; a … 57 (1978) 10, pp. 1-6,24

Persistent link: https://www.econbiz.de/10002716107

Wie weit greift der Risikoausschluss nach § 103 VVG bei obligatorischen Haftpflichtversicherungen?

Rubin, Daniel - In: Der Forschung - der Lehre - der Bildung : 100 Jahre …, (pp. 463-484). 2016

Persistent link: https://www.econbiz.de/10014576529

Anti-semitism and Zionism : selected Marxist writings

Rubin, Daniel (ed.) - 1987

Persistent link: https://www.econbiz.de/10013523355

Youth unemployment : causes and cures

Furillo, Jill; Rubin, Daniel - In: Political affairs : pa ; a Marxist monthly ; a … 59 (1980) 4, pp. 10-18

Persistent link: https://www.econbiz.de/10002185418

Pandemic pains to Instagram gains! : COVID-19 perceptions effects on behaviours towards fashion brands on Instagram in Sub-Saharan Africa : tech-native vs non-native generations

Mahmoud, Ali B.; Ball, Joan P.; Rubin, Daniel; Fuxman, … - In: Journal of marketing communications 28 (2022) 8, pp. 864-888

Persistent link: https://www.econbiz.de/10013493048

Vereinbarung von Preisänderungen bei Dauerschuldverhältnissen und KSchG

Fenyves, Attila - In: Bank-Archiv : Zeitschrift für das gesamte Bank- und … 52 (2004) 5, pp. 347 - 367

Persistent link: https://www.econbiz.de/10015151745

Exploring customer engagement tensions when pursuing responsible business practices

Gallan, Andrew S.; Hildebrand, Diogo; Loureiro, Yuliya … - In: Journal of service management 35 (2024) 4, pp. 464-489

Persistent link: https://www.econbiz.de/10015078048

Improving the FDA Approval Process

Malani, Anup; Bembom, Oliver; van der Laan, Mark - 2013

The FDA employs an average-patient standard when reviewing drugs: it approves a drug only if is safe and effective for the average patient in a clinical trial. It is common, however, for patients to respond differently to a drug. Therefore, the average-patient standard can reject a drug that...

Persistent link: https://www.econbiz.de/10014176528